Skip to main content

Table 2 Distribution of stakeholders for each type of technology according to the researchers’ perspective

From: Impact assessment of Iran’s health technology assessment programme

Stakeholders

Equipment technologies (17 cases)

Pharmaceutical technologies (3 cases)

Total technologies (20 cases)

Technology providersa

13 (76.5%)

3 (100.0%)

16 (80.0%)

Companies importing or producing technology

11 (64.7%)

3 (100.0%)

14 (70.0%)

Policy-makers providing and allocating finances to technologyb

13 (76.5%)

3 (100.0%)

16 (80.0%)

Policy-makers regulating technology-related research and innovation needsc

11 (64.7%)

2 (66.7%)

13 (65.0%)

Policy-makers regulating technology-related educational needs including Deputies of Education

5 (29.4%)

2 (66.7%)

7 (35.0%)

Public, patient associations, etc.

8 (47.1%)

3 (100.0%)

11 (55.0%)

  1. aInclude physicians, pharmacists, nurses, the Medical Council, Food and Drug Administration, etc.
  2. bIncludes the Offices of Insurance and Medical Equipment, the Supervisory and Financing Unit of Curative Affairs, the Iranian Parliament’s Health Commission, MOHME’s Policy-making Council, policy-makers at MOHME’s Clinical Governance and Hospital Management Unit, policy-makers at MOHME’s Standardisation and Tariff Office
  3. cIncludes Deputies of Research and Technology, Universities of Medical Sciences, etc.
Back to article page

Health Research Policy and Systems

ISSN: 1478-4505

Contact us